# Future Work & Translational Impact

This document outlines future research directions and potential translational applications of the linear perturbation prediction evaluation framework.

---

## üî¨ Research Directions

### 1. Multi-Dimensional Hardness Metrics

**Current State:** Hardness is defined as mean cosine similarity to top-K training perturbations (single dimension).

**Future Work:**
- **Multi-factor hardness:** Combine similarity, sample size, embedding quality, and prediction variance
- **Embedding-agnostic hardness:** Develop hardness metrics that work across different embedding spaces
- **Biological hardness:** Incorporate biological distance metrics (e.g., pathway distance, GO term similarity)

**Impact:** More accurate prediction of model performance on new perturbations, enabling better model selection and uncertainty quantification.

---

### 2. Cross-Dataset Transfer Learning

**Current State:** Embeddings are dataset-specific (PCA) or pretrained on external data (scGPT, scFoundation).

**Future Work:**
- **Unified embedding space:** Develop methods to align embeddings across datasets
- **Transfer learning protocols:** Systematic evaluation of cross-dataset embedding transfer
- **Meta-learning:** Learn to adapt embeddings to new datasets with few examples

**Impact:** Enable prediction on new cell types/datasets without retraining, accelerating discovery.

---

### 3. Functional Class-Aware Evaluation

**Current State:** LOGO evaluates on single functional class holdout (e.g., "Transcription").

**Future Work:**
- **Multi-class holdout:** Evaluate on multiple functional classes simultaneously
- **Hierarchical class structure:** Leverage GO hierarchy for more nuanced evaluation
- **Class-specific baselines:** Develop embeddings optimized for specific functional classes

**Impact:** More realistic evaluation scenarios, better understanding of biological generalization.

---

### 4. Uncertainty Quantification

**Current State:** Bootstrap CIs provide uncertainty for mean performance metrics.

**Future Work:**
- **Per-perturbation uncertainty:** Predict confidence intervals for individual predictions
- **Calibrated uncertainty:** Ensure predicted uncertainties match observed error distributions
- **Active learning:** Use uncertainty to guide experimental design (which perturbations to test next)

**Impact:** Enable risk-aware decision making in experimental design and clinical applications.

---

### 5. Ensemble Methods

**Current State:** Each baseline is evaluated independently.

**Future Work:**
- **Baseline ensembles:** Combine predictions from multiple baselines (e.g., scGPT + self-trained)
- **Weighted ensembles:** Learn optimal weights based on hardness or functional class
- **Dynamic ensemble selection:** Select baselines per perturbation based on similarity

**Impact:** Improve prediction accuracy by leveraging strengths of different embedding strategies.

---

## üè• Translational Applications

### 1. Drug Response Prediction

**Application:** Predict gene expression changes in response to drug perturbations.

**Current Framework Contribution:**
- Evaluate embedding strategies for drug perturbation prediction
- Assess generalization to unseen drug classes (LOGO evaluation)
- Quantify uncertainty in predictions (bootstrap CIs)

**Translational Impact:**
- **Preclinical screening:** Prioritize drug candidates before expensive experiments
- **Personalized medicine:** Predict patient-specific drug responses
- **Drug repurposing:** Identify new uses for existing drugs

**Next Steps:**
- Apply framework to drug perturbation datasets (e.g., LINCS, Connectivity Map)
- Evaluate on clinical drug response data
- Develop drug-specific embedding strategies

---

### 2. Disease Gene Prioritization

**Application:** Predict expression changes for disease-associated gene perturbations.

**Current Framework Contribution:**
- Functional class holdout (LOGO) tests generalization to disease-relevant pathways
- Hardness metrics identify which disease genes are easier/harder to predict
- Baseline comparisons identify best embedding strategies for disease genes

**Translational Impact:**
- **Target identification:** Prioritize disease genes for therapeutic intervention
- **Mechanism understanding:** Predict downstream effects of disease mutations
- **Biomarker discovery:** Identify expression signatures of disease perturbations

**Next Steps:**
- Apply to disease-specific perturbation datasets (e.g., cancer cell lines, patient-derived cells)
- Evaluate on known disease genes (positive controls)
- Develop disease-specific embeddings

---

### 3. CRISPR Guide RNA Design

**Application:** Predict expression changes for CRISPR knockout perturbations.

**Current Framework Contribution:**
- LSFT evaluation tests similarity-based filtering for guide RNA selection
- Hardness metrics identify which genes are easier to predict (better guide targets)
- Baseline comparisons identify best embeddings for CRISPR perturbations

**Translational Impact:**
- **Guide RNA optimization:** Select guides that maximize predicted effects
- **Off-target prediction:** Predict unintended expression changes
- **Screening design:** Optimize CRISPR screening experiments

**Next Steps:**
- Apply to CRISPR perturbation datasets (e.g., DepMap, Project Score)
- Evaluate on experimental validation data
- Develop CRISPR-specific embedding strategies

---

### 4. Synthetic Biology Design

**Application:** Predict expression changes for synthetic genetic circuits.

**Current Framework Contribution:**
- Functional class holdout (LOGO) tests generalization to synthetic pathways
- Hardness metrics identify which circuit designs are easier to predict
- Uncertainty quantification enables risk-aware design

**Translational Impact:**
- **Circuit optimization:** Design genetic circuits with desired expression profiles
- **Failure prediction:** Identify circuit designs likely to fail before construction
- **Iterative design:** Use predictions to guide experimental iterations

**Next Steps:**
- Apply to synthetic biology datasets (e.g., engineered circuits, metabolic pathways)
- Evaluate on experimental validation data
- Develop synthetic biology-specific embeddings

---

## üìä Methodological Improvements

### 1. Advanced Resampling Methods

**Current State:** Bootstrap (percentile method) and permutation tests (sign-flip).

**Future Work:**
- **Bias-corrected bootstrap (BCa):** Improve CI accuracy for skewed distributions
- **Block bootstrap:** Handle dependencies in test perturbations
- **Wild bootstrap:** Handle heteroscedasticity in regression models
- **Bayesian bootstrap:** Incorporate prior information

**Impact:** More accurate uncertainty quantification, especially for small samples.

---

### 2. Hyperparameter Optimization

**Current State:** Fixed hyperparameters (PCA dim=10, ridge penalty=0.1).

**Future Work:**
- **Cross-validation:** Optimize hyperparameters per dataset/baseline
- **Bayesian optimization:** Efficient hyperparameter search
- **Adaptive hyperparameters:** Adjust based on hardness or functional class

**Impact:** Improve prediction accuracy by optimizing model parameters.

---

### 3. Interpretability Methods

**Current State:** Black-box predictions with limited interpretability.

**Future Work:**
- **Feature importance:** Identify which genes/embeddings drive predictions
- **Attention mechanisms:** Visualize which training perturbations are most relevant
- **Causal inference:** Distinguish correlation from causation in predictions

**Impact:** Enable biological interpretation of predictions, identify mechanisms.

---

## üéØ Short-Term Goals (Next 6 Months)

1. **Expand LOGO evaluation:**
   - Evaluate on multiple functional classes per dataset
   - Aggregate results across classes for meta-analysis

2. **Develop multi-dimensional hardness:**
   - Implement combined hardness metric
   - Validate on held-out test sets

3. **Cross-dataset transfer analysis:**
   - Systematic evaluation of embedding transfer
   - Identify best practices for cross-dataset prediction

4. **Application to drug response:**
   - Apply framework to LINCS/Connectivity Map data
   - Evaluate on clinical drug response data

---

## üöÄ Long-Term Vision (1-2 Years)

1. **Unified embedding framework:**
   - Single embedding space that works across datasets
   - Automatic adaptation to new cell types/datasets

2. **Real-time prediction platform:**
   - Web interface for perturbation prediction
   - API for integration with experimental workflows

3. **Clinical validation:**
   - Evaluate on patient-derived cell lines
   - Validate predictions against clinical outcomes

4. **Open-source ecosystem:**
   - Community-contributed embeddings and baselines
   - Standardized evaluation protocols

---

## üìö Publication Strategy

### Immediate (Current Work)

- **Manuscript:** Resampling-enabled evaluation framework
- **Focus:** Statistical rigor, baseline comparisons, hardness analysis
- **Target:** Nature Methods, Cell Systems, or Bioinformatics

### Near-Term (6-12 Months)

- **Application papers:** Drug response prediction, disease gene prioritization
- **Focus:** Translational impact, clinical validation
- **Target:** Nature Biotechnology, Cell, or Science Translational Medicine

### Long-Term (1-2 Years)

- **Methods paper:** Advanced resampling methods, multi-dimensional hardness
- **Focus:** Methodological innovations, open-source tools
- **Target:** Nature Methods, Bioinformatics, or Journal of Machine Learning Research

---

## ü§ù Collaboration Opportunities

1. **Experimental biologists:** Validate predictions on new perturbations
2. **Clinicians:** Apply to patient data, validate clinical relevance
3. **Computational biologists:** Contribute embeddings, baselines, evaluation protocols
4. **Software engineers:** Develop user-friendly interfaces, APIs

---

**Document Version:** 1.0  
**Last Updated:** [Date]  
**Maintained By:** [Your Name/Team]

